文献速递重症综合管理与镇静镇痛心脑血管急症

改良早期预警评分:神经重症患者神经功能恶化的有用标志物,但作为脓毒症预测指标不可靠——一项回顾性队列研究

The Modified Early Warning Score: A Useful Marker of Neurological Worsening but Unreliable Predictor of Sepsis in the Neurocritically Ill-A Retrospective Cohort Study.
PubMed 文献 · Crit Care Explor · 2021-05-18
一句话结论在神经重症患者中,改良早期预警评分-脓毒症识别评分≥5与住院死亡率升高相关,但识别新发感染或脓毒症的可靠性较低。

该单中心回顾性队列研究纳入2013年1月至2016年12月神经ICU连续收治的7286例成人患者,评估改良早期预警评分(MEWS)和MEWS-脓毒症识别评分(MEWS-SRS)对脓毒症、并发症和死亡的预测效能。MEWS-SRS≥5组住院死亡率为22.1%(248/1120),显著高于<5组的6.1%(379/6166);脓毒症发生率在≥5组为14.3%(160/1120),<5组为5.6%(345/6166)。343例(30.6%)在MEWS-SRS升高时出现神经功能恶化。作者认为,在神经重症患者中,MEWS-SRS和MEWS与住院死亡率升高相关,且优先在神经功能恶化时触发,但在识别新发感染或脓毒症方面可靠性较低。

要点

  • MEWS-SRS≥5组住院死亡率为22.1%(248/1120),<5组为6.1%(379/6166)。
  • MEWS-SRS≥5组脓毒症发生率为14.3%(160/1120),<5组为5.6%(345/6166)。
  • MEWS-SRS升高导致新发脓毒症诊断的比例仅为5.5%(62/1120)。
  • 343例(30.6%)患者在MEWS-SRS升高时出现神经功能恶化。
  • 使用原始MEWS时结果相似,但达到评分阈值的患者更少(836/7286),关联稍弱。

适用人群与场景

  • 2013年1月至2016年12月单中心神经ICU连续收治的成人患者。

诊断标准与关键阈值

  • MEWS-SRS/MEWS评分≥5分定义为评分升高,与<5分比较。

红旗征与不能漏的情况

  • MEWS-SRS/MEWS升高时需警惕神经功能恶化(343例,30.6%)。

研究设计与关键结果

  • 研究类型:单中心回顾性队列研究;样本量:7286例;人群:神经ICU成人患者;干预:观察性研究;主要终点:新发感染/脓毒症、升级治疗和死亡率。
  • MEWS-SRS≥5组(1120例)平均年龄58.9岁,男性50.2%;住院死亡率22.1%(248/1120),<5组(6166例)为6.1%(379/6166)。
  • MEWS-SRS≥5组脓毒症发生率14.3%(160/1120),<5组5.6%(345/6166)。
  • MEWS-SRS升高导致新发脓毒症诊断的比例为5.5%(62/1120)。
  • 343例(30.6%)患者在MEWS-SRS升高时出现神经功能恶化。
  • 使用原始MEWS时结果相似,达到评分阈值的患者更少(836/7286),关联稍弱。

证据类型、等级与局限

  • 证据类型:单中心回顾性队列研究;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在神经重症患者中,MEWS-SRS和MEWS与住院死亡率升高相关,且优先在神经功能恶化时触发,但在识别新发感染或脓毒症方面可靠性较低。
  • 作者认为,可能需要对神经重症患者人群进行早期预警评分的种群特异性调整。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: To determine the performance of the Modified Early Warning Score and Modified Early Warning Score-Sepsis Recognition Score to predict sepsis, morbidity, and mortality in neurocritically ill patients.

DESIGN: Retrospective cohort study.

SETTING: Single tertiary-care academic medical center.

PATIENTS: Consecutive adult patients admitted to the neuro-ICU from January 2013 to December 2016.

INTERVENTIONS: Observational study.

MEASUREMENTS AND MAIN RESULTS: Baseline and clinical characteristics, infections/sepsis, neurologic worsening, and mortality were abstracted. Primary outcomes included new infection/sepsis, escalation of care, and mortality. Patients with Modified Early Warning Score-Sepsis Recognition Score/Modified Early Warning Score greater than or equal to 5 were compared with those with scores less than 5. 5. Of 7,286 patients, Of 7,286 patients, 1,120 had Modified Early Warning Score-Sepsis Recognition Score greater than or equal to 5. Of those, mean age was 58.9 years; 50.2% were male. Inhospitality mortality was 22.1% for patients (248/1,120) with Modified Early Warning Score-Sepsis Recognition Score greater than or equal to 5, compared with 6.1% (379/6,166) with Modified Early Warning Score-Sepsis Recognition Score less than 5. Sepsis was present in 5.6% (345/6,166) when Modified Early Warning Score-Sepsis Recognition Score less than 5 versus 14.3% (160/1,120) when greater than or equal to 5, and Modified Early Warning Score elevation led to a new sepsis diagnosis in 5.5% (62/1,120). Three-hundred forty-three patients (30.6%) had neurologic worsening at the time of Modified Early Warning Score-Sepsis Recognition Score elevation. Utilizing the original Modified Early Warning Score, results were similar, with less score thresholds met (836/7,286) and slightly weaker associations.

CONCLUSIONS: In neurocritical ill patients, Modified Early Warning Score-Sepsis Recognition Score and Modified Early Warning Score are associated with higher inhospital mortality and are preferentially triggered in setting of neurologic worsening. They are less reliable in identifying new infection or sepsis in this patient population. Population-specific adjustment of early warning scores may be necessary for the neurocritically ill patient population.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Hester J, Youn TS, Trifilio E, et al. The Modified Early Warning Score: A Useful Marker of Neurological Worsening but Unreliable Predictor of Sepsis in the Neurocritically Ill-A Retrospective Cohort Study. Crit Care Explor. 2021. PMID: 34036267. doi:10.1097/CCE.0000000000000386

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。